Analysts who follow Adagio Therapeutics Inc (ADGI) on average expect it to fall -8.08% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns Adagio Therapeutics Inc an Analyst Ranking of 3, which means it ranks higher than 3 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating ADGI a Hold today. Find out what this means to you and get the rest of the rankings on ADGI!